BALAXIPharmaceuticals
Balaxi Pharmaceuticals Ltd — Quarterly Results & Earnings
₹15.67
-9.20%
Profit Growth YoY-95.42%Latest quarter
Sales Growth YoY-27.40%Latest quarter
Sales CAGR 5Y45.01%5 year compound
Profit CAGR 5Y32.75%5 year compound
📋
Quarterly Performance
YoY Profit Growth-95.42%
🔴 Significant decline
YoY Sales Growth-27.40%
🔴 Significant decline
OPM 5Y Average
16.50%Operating profit margin
EPS Growth 5Y
30.15%Interest Coverage
5.48Higher = safer debt servicing
ROE
11.61%ROCE
12.95%💡
Growth Analysis
Balaxi Pharmaceuticals Ltd reported YoY profit growth of -95.42% and revenue growth of -27.40% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 45.01% and profits at 32.75% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Balaxi Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.